269 related articles for article (PubMed ID: 33417985)
1. Recent advances of nanomedicine-based strategies in diabetes and complications management: Diagnostics, monitoring, and therapeutics.
Wang Y; Wang C; Li K; Song X; Yan X; Yu L; He Z
J Control Release; 2021 Feb; 330():618-640. PubMed ID: 33417985
[TBL] [Abstract][Full Text] [Related]
2. The Unprecedented Role of Gold Nanomaterial in Diabetes Management.
Kumari S; Kamboj VK; Rajpoot D; Teotia AK; Verma PK; Singh GN
Recent Pat Drug Deliv Formul; 2019; 13(3):219-227. PubMed ID: 30430950
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicine-Based Strategies for Diabetes: Diagnostics, Monitoring, and Treatment.
Lemmerman LR; Das D; Higuita-Castro N; Mirmira RG; Gallego-Perez D
Trends Endocrinol Metab; 2020 Jun; 31(6):448-458. PubMed ID: 32396845
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine for treatment of diabetes in an aging population: state-of-the-art and future developments.
Krol S; Ellis-Behnke R; Marchetti P
Nanomedicine; 2012 Sep; 8 Suppl 1():S69-76. PubMed ID: 22640905
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine for treatment of diabetes in an aging population: state-of-the-art and future developments.
Krol S; Ellis-Behnke R; Marchetti P
Maturitas; 2012 Sep; 73(1):61-7. PubMed ID: 22209199
[TBL] [Abstract][Full Text] [Related]
7. An Insight into the Polymeric Nanoparticles Applications in Diabetes Diagnosis and Treatment.
Dehghani P; Rad ME; Zarepour A; Sivakumar PM; Zarrabi A
Mini Rev Med Chem; 2023; 23(2):192-216. PubMed ID: 34784864
[TBL] [Abstract][Full Text] [Related]
8. A novel peptide nanomedicine for treatment of pancreatogenic diabetes.
Banerjee A; Onyuksel H
Nanomedicine; 2013 Aug; 9(6):722-8. PubMed ID: 23347897
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Nanotechnology-Based Diagnosis and Treatments of Diabetes.
Rao PV; Gan SH
Curr Drug Metab; 2015; 16(5):371-5. PubMed ID: 25429672
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology Advanced Strategies for the Management of Diabetes Mellitus.
Mohsen AM
Curr Drug Targets; 2019; 20(10):995-1007. PubMed ID: 30848199
[TBL] [Abstract][Full Text] [Related]
11. Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications.
Capretto L; Carugo D; Mazzitelli S; Nastruzzi C; Zhang X
Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1496-532. PubMed ID: 23933616
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies.
Haeri A; Osouli M; Bayat F; Alavi S; Dadashzadeh S
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1-14. PubMed ID: 29186990
[TBL] [Abstract][Full Text] [Related]
13. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
[TBL] [Abstract][Full Text] [Related]
14. Biofluidic material-based carriers: Potential systems for crossing cellular barriers.
Shende P; Trivedi R
J Control Release; 2021 Jan; 329():858-870. PubMed ID: 33053397
[TBL] [Abstract][Full Text] [Related]
15. Polymeric Micelles in Cancer Immunotherapy.
Wan Z; Zheng R; Moharil P; Liu Y; Chen J; Sun R; Song X; Ao Q
Molecules; 2021 Feb; 26(5):. PubMed ID: 33668746
[TBL] [Abstract][Full Text] [Related]
16. Managing diabetes with nanomedicine: challenges and opportunities.
Veiseh O; Tang BC; Whitehead KA; Anderson DG; Langer R
Nat Rev Drug Discov; 2015 Jan; 14(1):45-57. PubMed ID: 25430866
[TBL] [Abstract][Full Text] [Related]
17. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
18. Oral nanomedicine approaches for the treatment of psychiatric illnesses.
Dening TJ; Rao S; Thomas N; Prestidge CA
J Control Release; 2016 Feb; 223():137-156. PubMed ID: 26739547
[TBL] [Abstract][Full Text] [Related]
19. Nanodrugs: pharmacokinetics and safety.
Onoue S; Yamada S; Chan HK
Int J Nanomedicine; 2014; 9():1025-37. PubMed ID: 24591825
[TBL] [Abstract][Full Text] [Related]
20. Polymeric nanoparticles for targeted treatment in oncology: current insights.
Prabhu RH; Patravale VB; Joshi MD
Int J Nanomedicine; 2015; 10():1001-18. PubMed ID: 25678788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
